| 摘要 |
<p>Pharmaceutical compositions and methods are disclosed using trospium and/or its metabolites, and pro-drugs with antimuscarinic smooth muscle relaxant properties, administered as a subcutaneous injection, implant or other depot preparation for the treatment of urinary incontinence, and other smooth muscle hyperactivity disorders thus avoiding the poor bioavailability of oral administration.</p> |
